A Closer Look at Pegcetacoplan and Zimura for Dry AMD Treatment
Age-Related Macular Degeneration (AMD) is a progressive eye condition that affects millions of people worldwide, leading to vision impairment and even blindness. Among its two main subtypes, Dry AMD is the more prevalent form, accounting for about 80% of all AMD cases. In this blog, we will delve into the symptoms of Dry AMD , explore the companies actively engaged in the Dry AMD market, and discuss the exciting developments in Dry AMD treatment. What are Dry AMD symptoms? Dry AMD, also known as non-neovascular or atrophic AMD, typically progresses slowly and often goes unnoticed until significant vision impairment occurs. Some common symptoms of Dry AMD include: 1. Blurred Vision: Patients may experience blurry central vision, making it difficult to recognize faces, read, or drive. 2. Difficulty Seeing in Low Light: Dry AMD can cause decreased night vision and difficulty adapting to dimly lit environments. 3. Visual Distortions: Straight lines may appear wavy or distorted, which c